These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8578817)

  • 1. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.
    Soltysik S; Wu JY; Recchia J; Wheeler DA; Newman MJ; Coughlin RT; Kensil CR
    Vaccine; 1995; 13(15):1403-10. PubMed ID: 8578817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure/function studies on QS-21, a unique immunological adjuvant from Quillaja saponaria.
    Kensil CR; Soltysik S; Wheeler DA; Wu JY
    Adv Exp Med Biol; 1996; 404():165-72. PubMed ID: 8957293
    [No Abstract]   [Full Text] [Related]  

  • 3. QS-21 structure/function studies: effect of acylation on adjuvant activity.
    Liu G; Anderson C; Scaltreto H; Barbon J; Kensil CR
    Vaccine; 2002 Jun; 20(21-22):2808-15. PubMed ID: 12034108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
    Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
    J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QS-21 and QS-7: purified saponin adjuvants.
    Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
    Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
    Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
    Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
    Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
    Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in saponin-based adjuvants.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
    Xie Y; Deng W; Sun H; Li D
    Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
    Fernández-Tejada A; Tan DS; Gin DY
    Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
    Kensil CR; Patel U; Lennick M; Marciani D
    J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
    Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
    Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant activity of QS-21 isomers.
    Soltysik S; Bedore DA; Kensil CR
    Ann N Y Acad Sci; 1993 Aug; 690():392-5. PubMed ID: 8368766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The muramyl dipeptide analog GMTP-N-DPG preferentially induces cellular immunity to soluble antigens.
    Fast DJ; Vosika GJ
    Vaccine; 1997 Nov; 15(16):1748-52. PubMed ID: 9364678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng.
    Sun H; Yang Z; Ye Y
    Int Immunopharmacol; 2006 Jan; 6(1):14-25. PubMed ID: 16332509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
    Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
    Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
    Wu JY; Gardner BH; Murphy CI; Seals JR; Kensil CR; Recchia J; Beltz GA; Newman GW; Newman MJ
    J Immunol; 1992 Mar; 148(5):1519-25. PubMed ID: 1538134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
    Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
    Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.